Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today’s episode we’re digging into this deal to see what it may mean to biotech investors.
Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today’s episode we’re digging into this deal to see what it may mean to biotech investors.